← All stocks

PLIANT THERAPEUTICS, INC.

PLRX Scheduled selling only

CIK 0001746473 #4543 in the set updated 22 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$163.62K

$163.62K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 4 sales

Net

−$163.62K

$0.00 against sales at will

By person

7 insiders · 4 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Coulie Bernard

President and CEO

—

$114.40K (1) scheduled

−$114.40K

505,601

0.8165%

$647.17K

+4.3%

Cummings Keith Lamont

Chief Financial Officer

—

$30.72K (1) scheduled

−$30.72K

297,214

0.4800%

$380.43K

+4.4%

Cheung Lily

Chief Human Resource Officer

—

$9.64K (1) scheduled

−$9.64K

44,847

0.0724%

$57.40K

+48.3%

Kuo Minnie

Chief Operating Officer

—

$8.85K (1) scheduled

−$8.85K

37,806

0.0611%

$48.39K

−15.5%

Hull Hans

Chief Business Officer

—

251,708

0.4065%

$322.19K

+10.6%

Lefebvre Eric

Chief Medical Officer

—

240,224

0.3879%

$307.49K

+12.8%

Ouimette Mike

General Counsel & Corp. Sec'y

—

105,544

0.1704%

$135.10K

+12.2%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 20

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 9 Jun 2020